News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonists
- P53, GHRH, inflammation and cancer
- The Role of Melatonin in Colorectal Cancer
- Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses
- Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel
- Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer
- Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy
- CLL: a supplementary question?
- Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia
- Melatonin: an anti-tumor agent for osteosarcoma
- Additively protective effects of vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: A systematic review and meta-analysis
- Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling
- A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates
- Melatonin and its ubiquitous anticancer effects
- The potential therapeutic actions of melatonin in colorectal cancer
- Duodenal neuroendocrine tumour associated with minimal change glomerulonephritis
- Retinoic acid upregulates cone arrestin expression in retinoblastoma cells through a Cis element in the distal promoter region
- Retinoic acid increases hydroxyindole-O-methyltransferase activity and mRNA in human Y-79 retinoblastoma cells
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- About melatonin - 1996
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Bibliography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- How effective is chemo therapy?
- Frequently Asked Questions
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways